Search Results - "Altaras, M."

Refine Results
  1. 1

    High incidence of BRCA1–2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma by Biron-Shental, T., Drucker, L., Altaras, M., Bernheim, J., Fishman, A.

    Published in European journal of surgical oncology (01-12-2006)
    “…To test the carrier status of the three germline founder mutations in Jewish patients with uterine serous papillary carcinoma (USPC) and to evaluate its…”
    Get full text
    Journal Article
  2. 2

    Uterine sarcomas versus leiomyomas: Gray-scale and Doppler sonographic findings by Aviram, Rami, Ochshorn, Yifat, Markovitch, Ofer, Fishman, Ami, Cohen, Ilan, Altaras, Marco M., Tepper, Ron

    Published in Journal of clinical ultrasound (01-01-2005)
    “…Purpose The aim of the study was to evaluate the contribution of gray‐scale sonography and Doppler flow studies in differentiating between uterine sarcomas of…”
    Get full text
    Journal Article
  3. 3

    Ovarian Overstimulation and Cystic Formation in Premenopausal Tamoxifen Exposure: Comparison between Tamoxifen-Treated and Nontreated Breast Cancer Patients by Cohen, Ilan, Figer, Arie, Tepper, Ron, Shapira, Jeremiah, Altaras, Marco M., Yigael, Dror, Beyth, Yoram

    Published in Gynecologic oncology (01-02-1999)
    “…Aim.Tamoxifen is the antihormonal treatment of choice for premenopausal breast cancer patients with advanced breast disease. Its premenopausal administration…”
    Get full text
    Journal Article
  4. 4

    Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridization by Fishman, A, Shalom-Paz, E, Fejgin, M, Gaber, E, Altaras, M, Amiel, A

    “…Our objective was to compare the genetic abnormalities in the primary tumors of epithelial ovarian cancer and their associated secondary peritoneal implants…”
    Get more information
    Journal Article
  5. 5

    Scaleable Production of Adenoviral Vectors by Transfection of Adherent PER.C6 Cells by Subramanian, Shyamsundar, Kim, Jong Joseph, Harding, Frances, Altaras, Gina M., Aunins, John G., Zhou, Weichang

    Published in Biotechnology progress (01-09-2007)
    “…Recombinant adenoviruses are efficient gene delivery vectors that are being evaluated in many gene therapy and vaccine applications. Methods for rapid…”
    Get full text
    Journal Article
  6. 6

    Endometrial pathology in postmenopausal tamoxifen treatment: comparison between gynaecologically symptomatic and asymptomatic breast cancer patients by Cohen, I, Perel, E, Flex, D, Tepper, R, Altaras, M M, Cordoba, M, Beyth, Y

    Published in Journal of clinical pathology (01-04-1999)
    “…AIMS: To evaluate whether endometrial pathology is more likely to be diagnosed in gynaecologically symptomatic rather than in gynaecologically asymptomatic…”
    Get full text
    Journal Article
  7. 7

    Pilot-Scale Adenovirus Seed Production through Concurrent Virus Release and Concentration by Hollow Fiber Filtration by Subramanian, Shyamsundar, Altaras, Gina M., Chen, Jennifer, Hughes, Benjamin S., Zhou, Weichang, Altaras, Nedim Emil

    Published in Biotechnology progress (01-05-2005)
    “…Recovery of recombinant adenoviruses from infected mammalian cell cultures often requires multiple unit operations such as cell lysis for virus release,…”
    Get full text
    Journal Article
  8. 8

    Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature by Cohen, I, Altaras, M M, Lew, S, Tepper, R, Beyth, Y, Ben-Baruch, G

    Published in Gynecologic oncology (01-12-1994)
    “…We present the first case of ovarian endometrioid carcinoma and endometriosis in a postmenopausal patient who was treated with tamoxifen for breast cancer. The…”
    Get more information
    Journal Article
  9. 9

    Endometrial changes with tamoxifen: comparison between tamoxifen-treated and nontreated asymptomatic, postmenopausal breast cancer patients by Cohen, I, Rosen, D J, Shapira, J, Cordoba, M, Gilboa, S, Altaras, M M, Yigael, D, Beyth, Y

    Published in Gynecologic oncology (01-02-1994)
    “…Endometrial thickness, as evaluated by vaginal ultrasonography, and endometrial histologic findings, as well as demographic characteristics, health habits, and…”
    Get more information
    Journal Article
  10. 10

    Complete Hydatidiform Mole and a Coexistent Viable Fetus: Report of Two Cases and Review of the Literature by Bruchim, I., Kidron, D., Amiel, A., Altaras, M., Fejgin, M.D.

    Published in Gynecologic oncology (01-04-2000)
    “…Objective. The aim of this study was to report the clinical features, management, and outcome of two cases of complete hydatidiform mole with a coexisting…”
    Get full text
    Journal Article
  11. 11

    Frequency of BRCA Mutations in Primary Peritoneal Carcinoma in Israeli Jewish Women by Menczer, J., Chetrit, A., Barda, G., Lubin, F., Fishler, Y., Altaras, M., Levavi, H., Struewing, J.P., Sadetzki, S., Modan, B.

    Published in Gynecologic oncology (2003)
    “…Objective. The aim of the present study was to compare demographic and clinical characteristics of primary peritoneal carcinoma (PPC) to ovarian carcinoma…”
    Get full text
    Journal Article
  12. 12

    Value of Sonohysterography in Asymptomatic Postmenopausal Tamoxifen-Treated Patients by Tepper, Ron, Beyth, Yoram, Altaras, Marco M., Zalel, Yaron, Shapira, Jeremiah, Cordoba, Mario, Cohen, Ilan

    Published in Gynecologic oncology (01-03-1997)
    “…A prospective study was performed to assess the efficacy of sonohysterography (SHG) in identifying endometrial pathologies among asymptomatic, postmenopausal…”
    Get full text
    Journal Article
  13. 13

    Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer by Cohen, I, Rosen, D J, Shapira, J, Cordoba, M, Gilboa, S, Altaras, M M, Yigael, D, Beyth, Y

    “…To evaluate whether risk factors, other than tamoxifen, can be identified for the development of endometrial pathologies in postmenopausal breast cancer…”
    Get more information
    Journal Article
  14. 14

    Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patients by COHEN, I, PEREL, E, YIGAEL, D, BEYTH, Y, TEPPER, R, FLEX, D, FIGER, A, SHAPIRA, J, ALTARAS, M. M, FISHMAN, A, BERNHEIM, J, CORDOBA, M

    Published in Breast cancer research and treatment (01-02-1999)
    “…To assess whether a higher cumulative tamoxifen dose is associated with increased incidence of various types of endometrial pathologies, we compared cumulative…”
    Get full text
    Journal Article
  15. 15

    Detection of Micrometastasis by Cytokeratin-20 (Reverse Transcription Polymerase Chain Reaction) in Lymph Nodes of Patients with Endometrial Cancer by Fishman, Amiram, Klein, Ami, Zemer, Ruth, Zimlichman, Shulamit, Bernheim, Joelle, Cohen, Ilan, Altaras, Marco M.

    Published in Gynecologic oncology (01-06-2000)
    “…Background. Cytokeratins are constituents of the intermediate filaments (IFs) of epithelial cells which are expressed in various combinations, depending on the…”
    Get full text
    Journal Article
  16. 16

    Asynchronous replication of homologous alpha-satellite DNA loci in man is associated with nondisjunction by Litmanovitch, T, Altaras, M M, Dotan, A, Avivi, L

    Published in Cytogenetics and cell genetics (01-01-1998)
    “…We tested the hypothesis that loss of replication control of DNA loci associated with human centromeres affects the main centromere function, namely, ensuring…”
    Get more information
    Journal Article
  17. 17

    Combination of endometrial thickness and time since menopause in predicting endometrial cancer in women with postmenopausal bleeding by Bruchim, Ilan, Biron-Shental, Tal, Altaras, Marco M., Fishman, Ami, Beyth, Yoram, Tepper, Ronnie, Aviram, Rami

    Published in Journal of clinical ultrasound (01-06-2004)
    “…Purpose This study was conducted to assess the combination of endometrial thickness, as measured by transvaginal sonography, and time since menopause, in…”
    Get full text
    Journal Article
  18. 18

    Detection of Tumor Circulating Cells by Cytokeratin 20 in the Blood of Patients with Endometrial Carcinoma by Klein, Ami, Fishman, Amiram, Zemer, Ruth, Zimlichman, Shulamit, Altaras, Marco M.

    Published in Gynecologic oncology (01-09-2000)
    “…Background. Cytokeratins are constituents of the intermediate filaments of epithelial cells which are expressed in various combinations depending on the…”
    Get full text
    Journal Article
  19. 19

    Adenomyosis in Postmenopausal Breast Cancer Patients Treated with Tamoxifen: A New Entity? by Cohen, Ilan, Beyth, Yoram, Tepper, Ron, Figer, Arie, Shapira, Jeremiah, Cordoba, Mario, Yigael, Dror, Altaras, Marco M.

    Published in Gynecologic oncology (01-07-1995)
    “…Between September 1, 1989 and October 31, 1994, 173 post-menopausal breast cancer women on tamoxifen treatment were followed up in the authors' institutions…”
    Get full text
    Journal Article
  20. 20

    Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations by Ramus, S.J., Fishman, A., Pharoah, P.D.P., Yarkoni, S., Altaras, M., Ponder, B.A.J.

    Published in European journal of surgical oncology (01-04-2001)
    “…Purpose: To compare the clinical characteristics and survival of Ashkenazi Jewish ovarian cancer patients with and without BRCA1 and BRCA2 mutations. Methods:…”
    Get full text
    Journal Article